Steven L. Hoerter
2021 - Deciphera Pharmaceuticals
In 2021, Steven L. Hoerter earned a total compensation of $9.4M as President and Chief Executive Officer at Deciphera Pharmaceuticals, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $324,480 |
|---|---|
| Option Awards | $8,402,574 |
| Salary | $676,000 |
| Other | $11,600 |
| Total | $9,414,654 |
Hoerter received $8.4M in option awards, accounting for 89% of the total pay in 2021.
Hoerter also received $324.5K in non-equity incentive plan, $676K in salary and $11.6K in other compensation.
Rankings
In 2021, Steven L. Hoerter's compensation ranked 1,145th out of 12,415 executives tracked by ExecPay. In other words, Hoerter earned more than 90.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,145 out of 12,415 | 91st |
Division Manufacturing | 402 out of 5,505 | 93rd |
Major group Chemicals And Allied Products | 146 out of 2,375 | 94th |
Industry group Drugs | 122 out of 2,096 | 94th |
Industry Pharmaceutical Preparations | 81 out of 1,546 | 95th |
Pay ratio
| Steven L. Hoerter's Pay | $9,414,654 |
|---|---|
| Median Employee's Pay | $290,520 |
| Pay Ratio | 32to 1 |
In 2021, the annual total compensation of Steven L. Hoerter was $9,414,654.
The annual total compensation of the median employee at Deciphera Pharmaceuticals was $290,520.
The ratio of Steven L. Hoerter's pay to the pay of median employee was therefore 32 to one.
Source: SEC filing on April 26, 2022.
Hoerter's colleagues
We found four more compensation records of executives who worked with Steven L. Hoerter at Deciphera Pharmaceuticals in 2021.